LEXINGTON, Massachusetts,
June 11, 2013 /PRNewswire/ --
Shire's Chief Financial Officer, Graham
Hetherington will present at the Goldman Sachs 34th Annual
Global Healthcare Conference on Wednesday,
June 12th at 9:20 AM PT
/17:20 BST. Investors may access a
live audio webcast of the presentation at
http://www.shire.com/shireplc/en/investors.
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead
better lives.
Our strategy is to focus on developing and marketing innovative
specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases,
Gastrointestinal, Internal Medicine and Regenerative Medicine and
we are developing treatments for symptomatic conditions treated by
specialist physicians in other targeted therapeutic areas.
http://www.shire.com
For further information please contact:
Investor Relations:
Souheil Salah, ssalah@shire.com, +44-1256-894160
Erin K. Kelly,
erikelly@shire.com, +1-781-482-9541